59 related articles for article (PubMed ID: 30127466)
1. Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.
Yakushijin K; Ikezoe T; Ohwada C; Kudo K; Okamura H; Goto H; Yabe H; Yasumoto A; Kuwabara H; Fujii S; Kagawa K; Ogata M; Onishi Y; Kohno A; Watamoto K; Uoshima N; Nakamura D; Ota S; Ueda Y; Oyake T; Koike K; Mizuno I; Iida H; Katayama Y; Ago H; Kato K; Okamura A; Kikuta A; Fukuda T
Bone Marrow Transplant; 2019 May; 54(5):674-680. PubMed ID: 30127466
[TBL] [Abstract][Full Text] [Related]
2. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Richardson PG; Riches ML; Kernan NA; Brochstein JA; Mineishi S; Termuhlen AM; Arai S; Grupp SA; Guinan EC; Martin PL; Steinbach G; Krishnan A; Nemecek ER; Giralt S; Rodriguez T; Duerst R; Doyle J; Antin JH; Smith A; Lehmann L; Champlin R; Gillio A; Bajwa R; D'Agostino RB; Massaro J; Warren D; Miloslavsky M; Hume RL; Iacobelli M; Nejadnik B; Hannah AL; Soiffer RJ
Blood; 2016 Mar; 127(13):1656-65. PubMed ID: 26825712
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients.
Miyoshi S; Ito R; Katayama H; Dote K; Aibiki M; Hamada H; Okura T; Higaki J
Drug Des Devel Ther; 2014; 8():1211-9. PubMed ID: 25214765
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and risk factors of hepatic sinusoidal obstruction syndrome in children after hematopoietic stem cell transplantation: A single-center experience.
Kartal İ; Albayrak C; Dağdemir A; Dinçer OS; Şimşek HK; Özgen Ü; Albayrak D
Transfus Apher Sci; 2024 Jun; 63(3):103909. PubMed ID: 38467529
[TBL] [Abstract][Full Text] [Related]
5. Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation.
Tagami T; Matsui H; Fushimi K; Yasunaga H
Front Med (Lausanne); 2015; 2():7. PubMed ID: 25767801
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS).
Richardson P; Aggarwal S; Topaloglu O; Villa KF; Corbacioglu S
Bone Marrow Transplant; 2019 Dec; 54(12):1951-1962. PubMed ID: 30804485
[TBL] [Abstract][Full Text] [Related]
7. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.
Johnston KC; Bruno A; Pauls Q; Hall CE; Barrett KM; Barsan W; Fansler A; Van de Bruinhorst K; Janis S; Durkalski-Mauldin VL;
JAMA; 2019 Jul; 322(4):326-335. PubMed ID: 31334795
[TBL] [Abstract][Full Text] [Related]
8. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K;
Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034
[TBL] [Abstract][Full Text] [Related]
9. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Robak T; Jin J; Pylypenko H; Verhoef G; Siritanaratkul N; Drach J; Raderer M; Mayer J; Pereira J; Tumyan G; Okamoto R; Nakahara S; Hu P; Appiani C; Nemat S; Cavalli F;
Lancet Oncol; 2018 Nov; 19(11):1449-1458. PubMed ID: 30348538
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
Corbacioglu S; Jabbour EJ; Mohty M
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1271-1280. PubMed ID: 30797942
[TBL] [Abstract][Full Text] [Related]
11. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Effect of Recombinant Human Soluble Thrombomodulin for Hepatic Sinusoidal Obstruction Syndrome Model Mice.
Kanou S; Miyashita T; Yamamoto Y; Takada S; Nakura M; Okazaki M; Ohbatake Y; Nakanuma S; Makino I; Tajima H; Takamura H; Fushida S; Ohta T
In Vivo; 2020; 34(3):1037-1045. PubMed ID: 32354890
[TBL] [Abstract][Full Text] [Related]
13. Soluble Thrombomodulin Attenuates Endothelial Cell Damage in Hepatic Sinusoidal Obstruction Syndrome.
Takada S; Miyashita T; Yamamoto Y; Kanou S; Munesue S; Ohbatake Y; Nakanuma S; Okamoto K; Sakai S; Kinoshita J; Makino I; Nakamura K; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
In Vivo; 2018; 32(6):1409-1417. PubMed ID: 30348695
[TBL] [Abstract][Full Text] [Related]
14. Utility of liver stiffness measurement in the diagnosis of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation.
Inoue Y; Saitoh S; Denpo H; Yamaguchi K; Kubota K; Taya Y; Wake A; Masuda A; Ishiwata K
J Med Ultrason (2001); 2024 Apr; 51(2):311-321. PubMed ID: 38112930
[TBL] [Abstract][Full Text] [Related]
15. HokUS-10 scoring system predicts the treatment outcome for sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.
Shiratori S; Okada K; Sugita J; Nishida M; Iwai T; Ota S; Hashimoto D; Teshima T
Sci Rep; 2023 Oct; 13(1):17374. PubMed ID: 37833418
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic hypereosinophilic syndrome with hepatic sinusoidal obstruction syndrome: A case report and literature review.
Xu XT; Wang BH; Wang Q; Guo YJ; Zhang YN; Chen XL; Fang YF; Wang K; Guo WH; Wen ZZ
World J Gastrointest Surg; 2023 Jul; 15(7):1532-1541. PubMed ID: 37555104
[TBL] [Abstract][Full Text] [Related]
17. Living Donor Liver Transplantation for Hepatic Venoocclusive Disease/Sinusoidal Obstruction Syndrome Originating from Hematopoietic Stem Cell Transplantation.
Ichimura K; Kawamura N; Goto R; Watanabe M; Ganchiku Y; Shimamura T; Taketomi A
Case Rep Transplant; 2022; 2022():8361769. PubMed ID: 35637901
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites.
Yazaki T; Kawashima K; Ishimura N; Kataoka M; Fukunaga M; Hyakudomi R; Tajima Y; Moriyama I; Araki A; Kadota K; Shibagaki K; Tobita H; Ishihara S
Intern Med; 2022 Nov; 61(21):3225-3231. PubMed ID: 35370236
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
